7
Registered trials
3
Recruiting
7
Unique sponsors
9
Unique IMPs
2
Commercial trials
Drug classes (ATC)
—
ATC code not specified
5
N
Neurology/Psychiatry (ATC N)
2
Mechanism of action (INN-stem analysis)
Unknown / small molecule
9 substances
Phase II:
4
Phase IV:
1
Phase I:
1
Other:
1
Phase II
4 trials-
PendingCentre Hospitalier Universitaire Grenoble Alpes AcademicESCITALOPRAM; PRUCALOPRIDE SUCCINATE
-
RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS Academic[18F]MC225
-
RecruitingNarodni Ustav Dusevniho Zdravi AcademicKETAMINE HYDROCHLORIDE; MIDAZOLAM; PSILOCYBINE
-
PendingUniversity Of Gothenburg Academic3-(3-METHANESULFONYL-PHENYL)-1-PROPYL-PIPERIDINE HYDROCHLORIDE; PLACEBO
Phase IV
1 trial-
RecruitingAzienda Socio Sanitaria Territoriale Di Lodi AcademicCHOLINE ALFOSCERATE
Phase I
1 trial-
EndedLophora ApS CommercialIMP not specified
Other
1 trial-
EndedAngelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.p.A. CommercialIMP not specified
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| Lophora ApS | Commercial | 1 | Phase I | 0 |
| Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.p.A. | Commercial | 1 | Other | 0 |
| Centre Hospitalier Universitaire Grenoble Alpes | Academic | 1 | Phase II | 0 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Academic | 1 | Phase II | 1 |
| Narodni Ustav Dusevniho Zdravi | Academic | 1 | Phase II | 1 |
| University Of Gothenburg | Academic | 1 | Phase II | 0 |
| Azienda Socio Sanitaria Territoriale Di Lodi | Academic | 1 | Phase IV | 1 |
New trials by year
2022
1
2024
2
2025
2